Clinical Trials Directory

Trials / Conditions / Nimotuzumab

Nimotuzumab

6 registered clinical trials studyying Nimotuzumab2 currently recruiting.

StatusTrialSponsorPhase
RecruitingNimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinom
NCT06410651
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
RecruitingNimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
NCT06429839
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
UnknownCombination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma
NCT04664244
Lei LiPhase 2
CompletedA Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
NCT04207918
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
UnknownEGFR Monoclonal Antibody for Advanced Gastric Cancer
NCT04136600
Shanghai Changzheng HospitalPhase 2
UnknownImmunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
NCT03554889
Hangzhou Cancer HospitalPhase 1